In the video interview excerpt below, Motley Fool CEO Tom Gardner speaks with Middleby (NASDAQ: MIDD ) CEO Selim Bassoul. Since becoming CEO in 2000, Bassoul has led a remarkable transformation at Middleby, turning the cooking equipment maker's�stock into a nearly 50-bagger over that time. In the video below, Bassoul discusses how the company can continue its rapid growth.
Middleby is one of Tom Gardner's favorite stocks, but you can never have too many great companies in your portfolio. If you're looking for more ideas, our chief investment officer has selected a different stock as his favorite for this year. Find out which stock it is in the free report: "The Motley Fool's Top Stock for 2013." Just�click here�to access the report and find out the name of this under-the-radar company.
Tom Gardner:�I want to come back to something you said in that answer, but my second challenge to Middleby as an investment, it's been a 50-bagger. I mean it's difficult for an investor to see a stock double and buy it.� You see a stock at 15, now it's at 30. You're like, "Ah, I should have bought it at 15." Then when it goes from 30 to 60, you're like, "Ah, I could have bought it at 30. I could have bought it at 15 and now it's up four times and I missed it." This stock is up 50 times. You are almost never going to find in American history, a 13-year period where a company goes up 50 times in value, 35% per year.�
Top Heal Care Stocks To Watch For 2015: Crocs Inc.(CROX)
Crocs, Inc. and its subsidiaries engage in the design, development, manufacture, marketing, and distribution of footwear, apparel, and accessories for men, women, and children. The company primarily offers casual and athletic shoes, and shoe charms. It also designs and sells a range of footwear and accessories that utilize its proprietary closed cell-resin, called Croslite. The company?s footwear products include boots, sandals, sneakers, mules, and flats. In addition, it provides footwear products for the hospital, restaurant, hotel, and hospitality markets, as well as general foot care and diabetic-needs markets. Further, the company offers leather and ethylene vinyl acetate based footwear, sandals, and printed apparels principally for the beach, adventure, and action sports markets; and accessories comprising snap-on charms. The company sells its products through the United States and international retailers and distributors, as well as directly to end-user consumers th rough its company-operated retail stores, outlets, kiosks, and Web stores primarily under the Crocs Work, Crocs Rx, Jibbitz, Ocean Minded, and YOU by Crocs brand names. As of December 31, 2010, it operated 164 retail kiosks located in malls and other high foot traffic areas; 138 retail stores; 76 outlet stores; and 46 Web stores. Crocs, Inc. operates in the Americas, Europe, and Asia. The company was formerly known as Western Brands, LLC and changed its name to Crocs, Inc. in January 2005. Crocs, Inc. was founded in 1999 and is headquartered in Niwot, Colorado.
Advisors' Opinion:- [By Ben Levisohn]
Crocs (CROX) has dropped 5.5% to $12.93 after it was cut to Neutral from Overweight at Piper Jaffray.
CF Industries�(CF) has gained 3.6% to $$217.51 after it sold its phosphate business to�Mosaic�(MOS) for $1.4 billion. Mosaic edged up 0.1% to $45.98.
- [By Ben Eisen and Saumya Vaishampayan]
Crocs Inc. (CROX) �rose 2.2%. The shoe company was said to be in discussions with buyout firms, including Blackstone Group LP, according to Bloomberg, which cited anonymous sources. The talks appeared to be focused on the firm taking a minority stake in Crocs via which Blackstone could help map out a turnaround strategy.
Top Growth Stocks To Watch Right Now: MEDIFAST INC(MED)
Medifast, Inc., through its subsidiaries, engages in the production, distribution, and sale of weight management and disease management products, and other consumable health and diet products in the United States. The company?s product lines include weight and disease management, meal replacement, and vitamins. It also operates weight control centers that offer Medifast programs for weight loss and maintenance, customized patient counseling, and inbody composition analysis. The company markets its products under the Medifast and Essential brand names, including shakes, appetite suppression shakes, women?s health shakes, diabetics shakes, joint health shakes, coronary health shakes, calorie burn drinks, calorie burn flavor infusers, antioxidant shakes, antioxidant flavor infusers, bars, crunch bars, soups, chili, oatmeal, pudding, scrambled eggs, hot cocoa, cappuccino, chai latte, iced teas, fruit drinks, pretzels, puffs, brownie, pancakes, soy crisps, crackers, and omega 3 and digestive health products. Medifast Inc. sells its products through various channels of distribution comprising Web, call center, independent health advisors, medical professionals, weight loss clinics, and direct consumer marketing supported via the phone and the Web; Take Shape for Life, a physician led network of independent health coaches; and weight control centers. The company was founded in 1980 and is headquartered in Owings Mills, Maryland.
Advisors' Opinion:- [By Monica Gerson]
Analysts expect Medifast (NYSE: MED) to post its Q4 earnings at $0.36 per share on revenue of $80.83 million. Medifast shares surged 2.19% to close at $26.08 on Friday.
- [By Jon C. Ogg]
Medifast Inc. (NYSE: MED) saw its stock down 5% in evening trading on Tuesday after the weight loss player had soft sales and guided expectations lower. Shares were still indicated down about 5%, but volume has not yet started.
- [By Holly LaFon] ast produces, distributes and sells weight and health management products with the brand names Medifast, Take Shape for Life, Hi-Energy Weight Control Centers and Woman�� Wellbeing.
Its return on assets in the third quarter of 2011 was 19.6%, which has been increasing in the past several years. The average return on assets for the specialty retail industry is 10.48% for the trailing 12 months.
The company�� total assets amounted to $94 million in 2010, which increased from $62.8 million in 2009. Net income also increased to $19.6 million in 2010 from $12 million in 2009.
Boston Beer Inc. (SAM)
Boston Beer Inc. is the largest brewer of handcrafted beers in America. Boston Beer is a growing company that recently saw a large increase in its return on assets. It increased from 19.3% in 2010 to 29.7% in 2011, and was negative as recently as 2008. The average return on assets for the beverages industry in the trailing 12 months is 9.47%.
In 2011, the company�� total assets increased to $272.5 million from $258.5 million in 2010. Net income increased to $66 million from $50 million.
Alliances Resources Partners (ARLP)
Alliance Resources Partners is a coal producer and marketer primarily in the eastern U.S. Its ROA has been increasing since 2008 and increased to 22.5% in 2011 from 21.4% in 2010. The average return on assets for the oil, gas & consumable fuels industry in the trailing 12 months is 24.47%.
In 2011, its total assets increased to $1.7 billion from $1.1 billion in 2010. Its net income increased to $389 million from $321 million.
Factset Research Systems Inc. (FDS)
Factset researches global market trends and develops analytical tools for investors. Of all of GuruFocus��5-star predictable companies, it has the highest return on assets at 27%. ROA has been increasing over the past several years. The average return on assets for the software industry for the trailing 12 m
Top Growth Stocks To Watch Right Now: Buffalo Wild Wings Inc.(BWLD)
Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants in the United States. The company provides quick casual and casual dining services, as well as serves bottled beers, wines, and liquor. As of July 26, 2011, it had 773 Buffalo Wild Wings locations in 45 states in the United States, as well as in Canada. The company was founded in 1982 and is headquartered in Minneapolis, Minnesota.
Advisors' Opinion:- [By Steve Symington]
Meanwhile, its significantly larger beer-and-wings cousin,�Buffalo Wild Wings� (NASDAQ: BWLD ) , had just�managed to grow revenue 12% year over year -- a performance driven not only by new restaurant openings, but also by B-Wild's respective 5.2% and 3.1% same-store sales increases at company-owned and franchised restaurants. Of course, Buffalo Wild Wings shares also plunged the following day as a result of its cautious forward outlook, but the stock has since rebounded nicely as investors take solace knowing diners are still coming back in droves.
- [By Garrett Cook]
Buffalo Wild Wings (NASDAQ: BWLD) was down, falling 14.45 percent to $142.99 despite the company beating Q2 expectations and raising its 2014 outlook. Wunderlich Securities analyst Robert M. Derrington lowered the price target on the stock from $180.00 to $170.00.
- [By Monica Gerson]
Buffalo Wild Wings (NASDAQ: BWLD) shares jumped 8.86% to $140.98 in pre-market trading after the company reported upbeat third-quarter results.
Baidu (NASDAQ: BIDU) shares gained 7.80% to $171.85 in the pre-market session after the company reported higher Q3 profit. Brean Capital upgraded the stock from Hold to Buy.
- [By Louis Navellier]
Sports bar chain�Buffalo Wild Wings (BWLD) has had a stellar year, and BWLD stock price has gained more than 100%. It looks like the company will roll right into 2014 on a tear that should continue as people head out to watch all the Bowl games and NFL playoffs. Sales and earnings momentum are excellent, and the analysts are racing to catch up as a result of the chain’s success. BWLD has posted two consecutive earnings surprises, and estimates have been raised for the final three months of this year as well as all of 2014. The stock was upgraded to an “A” in November and remains a “strong buy” at the current price.
Top Growth Stocks To Watch Right Now: Thoratec Corporation(THOR)
Thoratec Corporation engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support. The company?s primary product lines include ventricular assist devices, such as HeartMate II, an implantable left ventricular assist device consisting of a rotary blood pump to provide intermediate and long-term mechanical circulatory support (MCS); and HeartMate XVE, an implantable and pulsatile left ventricular assist device for intermediate and longer-term MCS. Its ventricular assist devices also comprise Paracorporeal Ventricular Assist Device, an external pulsatile ventricular assist device, which provides left, right, and biventricular MCS approved for bridge-to-transplantation (BTT), including home discharge, and post-cardiotomy myocardial recovery; and Implantable Ventricular Assist Device, an implantable and pulsatile ventricular assist device designed to provide left, right, and biventricular MCS approved for BTT comprising hom e discharge, and post-cardiotomy myocardial recovery. The company also provides CentriMag, an extracorporeal full-flow acute surgical support platform that offers support up to 30 days for cardiac and respiratory failure. In addition, it offers PediMag and PediVAS extracorporeal full-flow acute surgical support platforms designed to provide acute surgical support to pediatric patients. The company sells its products through direct sales force in the United States, as well as through a network of distributors internationally. Thoratec Corporation was founded in 1976 and is headquartered in Pleasanton, California.
Advisors' Opinion:- [By Todd Campbell]
Competing for heart pump market share
Abiomed's products provide circulatory support for up to six hours and are designed for use in cardiac cath labs or during heart surgery, but competitors Thoratec (NASDAQ: THOR ) and Heartware (NASDAQ: HTWR ) target the intermediate- and long-term-use market instead. - [By Anna Prior]
Medical device company Thoratec Corp.(THOR) has purchased Apica Cardiovascular Ltd., in a deal that includes $35 million in cash upfront and potential milestone payments of up to $40 million.
- [By Brian Pacampara]
What: Shares of medical device company Thoratec (NASDAQ: THOR ) sank 12% today after its quarterly results missed Wall Street expectations. �
- [By Garrett Cook]
In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.62 percent. Meanwhile, top decliners in the sector included Thoratec (NASDAQ: THOR), down 30 percent, and PhotoMedex (NASDAQ: PHMD), off 15.11 percent.
Top Growth Stocks To Watch Right Now: Delphi Financial Group Inc. (DFG)
Delphi Financial Group, Inc., together with its subsidiaries, provides integrated employee benefit services. The company operates in two segments, Group Employee Benefit Products and Asset Accumulation Products. The Group Employee Benefit Products segment provides disability, group life, and excess workers? compensation insurance products to small and mid-sized employers. It also offers travel accident, voluntary accidental death and dismemberment, group dental, and limited benefit health insurance products, as well as assumed workers? compensation and casualty reinsurance. This segment markets its group products to employer-employee groups and associations in various industries primarily through independent brokers and agents. The Asset Accumulation Products segment primarily offers fixed annuities, such as single premium deferred annuities, flexible premium annuities, and multi-year interest guarantee products to individuals through networks of independent insurance agen ts. The company also provides integrated disability and absence management services, including event reporting, leave of absence management, claims and case management, and return to work management. Delphi Financial Group, Inc. was founded in 1987 and is based in Wilmington, Delaware.
Advisors' Opinion:- [By Holly LaFon]
Some of Elliott Management�� top equity positions in the first quarter 2012 are Brocade Communications Systems (BRCD), Delphi Automotive (DFG), Iron Mountain (IRM) and News Corp. (NWS).
Top Growth Stocks To Watch Right Now: Intuitive Surgical Inc.(ISRG)
Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Its da Vinci surgical system consists of a surgeon?s console or consoles, a patient-side cart, a 3-D vision system, and proprietary ?wristed? instruments. The company?s da Vinci surgical system translates the surgeon?s natural hand movements on instrument controls at the console into corresponding micro-movements of instruments positioned inside the patient through small puncture incisions, or ports. It also manufactures a range of EndoWrist instruments, which incorporate wrist joints for natural dexterity for various surgical procedures. Its EndoWrist instruments consist of forceps, scissors, electrocautery, scalpels, and other surgical tools. In addition, it sells various vision and accessory products for use in conjunction with the da Vinci Surgical System as surgical procedures are performed. The company?s accessory products include sterile drapes used to ensure a sterile field during surgery; vision products, such as replacement 3-D stereo endoscopes, camera heads, light guides, and other items. It markets its products through sales representatives in the United States, and through sales representatives and distributors in international markets. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Advisors' Opinion:- [By Brian Stoffel]
After the market closed yesterday, Intuitive Surgical (NASDAQ: ISRG ) �-- maker of the da Vinci Robotic Surgical System -- announced preliminary results for the second quarter that caused shares to plunge as much as 17% today.
- [By Anders Bylund]
Plenty of companies operate behind a business moat, which makes it hard for competitors to steal their thunder. Intuitive Surgical (NASDAQ: ISRG ) made its moat a mile wide, filled it with boiling acid, and populated it with mutant alligators.
- [By Dan Carroll]
All hands are on deck at Intuitive Surgical (NASDAQ: ISRG ) after the market's most prominent robotic surgical stock plunged by double digits in after-hours trading on Thursday. Intuitive released earnings, and the company's latest financial report dazzled no one, a sharp contrast to the stellar performance investors have gotten used to from this innovative health-care star.
No comments:
Post a Comment